| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 243.08B | 277.74B | 237.86B | 213.90B | 209.11B | 199.19B |
| Gross Profit | 40.25B | 50.62B | 38.12B | 28.44B | 25.04B | 24.61B |
| EBITDA | 26.88B | 27.32B | 23.59B | 16.46B | 13.97B | 13.38B |
| Net Income | 11.50B | 18.84B | 11.40B | 8.84B | 9.41B | 9.35B |
Balance Sheet | ||||||
| Total Assets | 186.55B | 206.88B | 197.71B | 161.58B | 156.65B | 147.36B |
| Cash, Cash Equivalents and Short-Term Investments | 12.33B | 10.76B | 19.45B | 7.34B | 4.04B | 3.36B |
| Total Debt | 51.18B | 39.48B | 54.73B | 30.28B | 40.95B | 39.17B |
| Total Liabilities | 101.58B | 100.86B | 112.08B | 84.45B | 88.26B | 88.42B |
| Stockholders Equity | 83.31B | 98.39B | 83.66B | 75.91B | 67.50B | 58.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.37B | 6.16B | 14.06B | -324.00M | -4.14B |
| Operating Cash Flow | 0.00 | 16.23B | 13.11B | 17.74B | 4.16B | 428.00M |
| Investing Cash Flow | 0.00 | -2.48B | 71.00M | 1.02B | -3.42B | -1.52B |
| Financing Cash Flow | 0.00 | -22.35B | -1.45B | -15.63B | -213.00M | 64.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥2.16T | 7.87 | 12.05% | 1.50% | 9.27% | 3.50% | |
72 Outperform | ¥465.18B | 18.92 | 18.90% | 1.64% | 16.76% | 65.02% | |
70 Outperform | ¥646.96B | 12.64 | 9.63% | 2.12% | 4.94% | 37.62% | |
69 Neutral | ¥10.21T | 43.08 | 32.32% | 0.91% | 20.73% | 72.44% | |
68 Neutral | ¥3.83T | 27.94 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥1.83T | 36.88 | 8.39% | 1.49% | 0.83% | -37.84% |